These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
753 related articles for article (PubMed ID: 18311189)
1. The neurocircuitry of addiction: an overview. Feltenstein MW; See RE Br J Pharmacol; 2008 May; 154(2):261-74. PubMed ID: 18311189 [TBL] [Abstract][Full Text] [Related]
2. Neuropharmacology of addiction--setting the scene. Lawrence AJ; Beart PM; Kalivas PW Br J Pharmacol; 2008 May; 154(2):259-60. PubMed ID: 18414384 [TBL] [Abstract][Full Text] [Related]
3. A neuropeptide-centric view of psychostimulant addiction. Boutrel B Br J Pharmacol; 2008 May; 154(2):343-57. PubMed ID: 18414383 [TBL] [Abstract][Full Text] [Related]
4. Addiction and brain reward and antireward pathways. Gardner EL Adv Psychosom Med; 2011; 30():22-60. PubMed ID: 21508625 [TBL] [Abstract][Full Text] [Related]
6. From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? McGregor IS; Callaghan PD; Hunt GE Br J Pharmacol; 2008 May; 154(2):358-68. PubMed ID: 18475254 [TBL] [Abstract][Full Text] [Related]
7. The synaptic pathology of drug addiction. Van den Oever MC; Spijker S; Smit AB Adv Exp Med Biol; 2012; 970():469-91. PubMed ID: 22351069 [TBL] [Abstract][Full Text] [Related]
8. Neuropharmacology of alcohol addiction. Vengeliene V; Bilbao A; Molander A; Spanagel R Br J Pharmacol; 2008 May; 154(2):299-315. PubMed ID: 18311194 [TBL] [Abstract][Full Text] [Related]
9. Relapse to drug-seeking: neural and molecular mechanisms. Self DW; Nestler EJ Drug Alcohol Depend; 1998; 51(1-2):49-60. PubMed ID: 9716929 [TBL] [Abstract][Full Text] [Related]
10. Neuroplasticity in the mesolimbic dopamine system and cocaine addiction. Thomas MJ; Kalivas PW; Shaham Y Br J Pharmacol; 2008 May; 154(2):327-42. PubMed ID: 18345022 [TBL] [Abstract][Full Text] [Related]
11. From neurobiology to treatment: progress against addiction. Nestler EJ Nat Neurosci; 2002 Nov; 5 Suppl():1076-9. PubMed ID: 12403990 [TBL] [Abstract][Full Text] [Related]
12. Systems level neuroplasticity in drug addiction. Feltenstein MW; See RE Cold Spring Harb Perspect Med; 2013 May; 3(5):a011916. PubMed ID: 23580792 [TBL] [Abstract][Full Text] [Related]
13. New medications for drug addiction hiding in glutamatergic neuroplasticity. Kalivas PW; Volkow ND Mol Psychiatry; 2011 Oct; 16(10):974-86. PubMed ID: 21519339 [TBL] [Abstract][Full Text] [Related]
14. Neural Substrates and Circuits of Drug Addiction. Feltenstein MW; See RE; Fuchs RA Cold Spring Harb Perspect Med; 2021 Apr; 11(4):. PubMed ID: 32205414 [TBL] [Abstract][Full Text] [Related]
15. Drug dependence as a disorder of neural plasticity: focus on dopamine and glutamate. Pulvirenti L; Diana M Rev Neurosci; 2001; 12(2):141-58. PubMed ID: 11392455 [TBL] [Abstract][Full Text] [Related]
16. Perspective: Translational studies on glutamate and dopamine neurocircuitry in addictions: implications for addiction treatment. Lambe EK; George TP Neuropsychopharmacology; 2009 Jan; 34(2):255-6. PubMed ID: 18987625 [TBL] [Abstract][Full Text] [Related]
17. The distribution of neurotransmitters in the brain circuitry: Mesolimbic pathway and addiction. Ebrahimi MN; Banazadeh M; Alitaneh Z; Jaafari Suha A; Esmaeili A; Hasannejad-Asl B; Siahposht-Khachaki A; Hassanshahi A; Bagheri-Mohammadi S Physiol Behav; 2024 Oct; 284():114639. PubMed ID: 39004195 [TBL] [Abstract][Full Text] [Related]
18. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Weiss F; Ciccocioppo R; Parsons LH; Katner S; Liu X; Zorrilla EP; Valdez GR; Ben-Shahar O; Angeletti S; Richter RR Ann N Y Acad Sci; 2001 Jun; 937():1-26. PubMed ID: 11458532 [TBL] [Abstract][Full Text] [Related]
19. The good and bad news about glutamate in drug addiction. Spencer S; Scofield M; Kalivas PW J Psychopharmacol; 2016 Nov; 30(11):1095-1098. PubMed ID: 27353027 [TBL] [Abstract][Full Text] [Related]
20. Neurobiology of addiction. Toward the development of new therapies. Koob GF Ann N Y Acad Sci; 2000; 909():170-85. PubMed ID: 10911930 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]